Abstract 933: Pre-clinical characterization of TIM-3 antibody NB002 von Dong, Xin, Dong, Jannie, Ma, Jun, Zhao, Lianqi, Wang, Haojie, Wang, Binbin, Gao, Qian, Pan, Hui, Wang, Dong, Shao, Liegang

Volltext

Abstract 1867: Pre-clinical characterization of anti-CEACAM1 antibody von Dong, Jinyu, Zhang, Yu, Wang, Baiyang, Pu, Tingting, Shao, Liegang, Wang, Binbin, Wang, Dong, Ni, Jie, Li, Sunan, Dong, Xin

Volltext

Abstract 6366: NB002, a novel therapeutic antibody targeting unique epitope on TIM-3 presenting potent antitumor activity von Zhang, Yu, Dong, Jinyu, Wang, Binbin, Ni, Jie, Wang, Dong, Shao, Liegang, Xiong, Meiguang, Wang, Ting, McAllister, Florencia, Dong, Xin

Volltext

TIM-3-targeting antibodies and uses thereof von Wang, Dong, Wang, Baiyang, Ma, Jun, Wang, Binbin, Zhang, Yu, Shao, Liegang, Wang, Haojie, Dong, Jinyu, Gao, Qian, Dong, Xin

Volltext bestellen

PD-L1 ANTIBODIES, FUSION PROTEINS, AND USES THEREOF von ZHANG, Yu, ZHOU, Zhou, DONG, Xin, ZHAO, Lianqi, WANG, Binbin, DONG, Jinyu, WANG, Dong, WANG, Baiyang, SHAO, Liegang

Volltext bestellen

TIM-3-TARGETING ANTIBODIES AND USES THEREOF von Wang, Dong, Wang, Baiyang, ZHANG, Yu, Ma, Jun, Wang, Binbin, Shao, Liegang, Wang, Haojie, Dong, Jinyu, Gao, Qian, Dong, Xin

Volltext bestellen

PD-L1 ANTIBODIES, FUSION PROTEINS, AND USES THEREOF von Wang, Dong, Wang, Baiyang, Wang, Binbin, Zhao, Lianqi, Zhang, Yu, Zhou, Zhou, Shao, Liegang, Dong, Jinyu, Dong, Xin

Volltext bestellen

PD-L1 ANTIBODIES, FUSION PROTEINS, AND USES THEREOF von ZHANG, Yu, ZHOU, Zhou, DONG, Xin, ZHAO, Lianqi, WANG, Binbin, DONG, Jinyu, WANG, Dong, WANG, Baiyang, SHAO, Liegang

Volltext bestellen

TIM-3-TARGETTING ANTIBODIES AND USES THEREOF von ZHANG, Yu, DONG, Xin, WANG, Binbin, DONG, Jinyu, GAO, Qian, WANG, Dong, WANG, Baiyang, SHAO, Liegang, WANG, Haojie, MA, Jun

Volltext bestellen

PD-L1 ANTIBODIES, FUSION PROTEINS, AND USES THEREOF von ZHANG, Yu, ZHOU, Zhou, DONG, Xin, ZHAO, Lianqi, WANG, Binbin, DONG, Jinyu, WANG, Dong, WANG, Baiyang, SHAO, Liegang

Volltext bestellen

PD-L1 ANTIBODIES, FUSION PROTEINS, AND USES THEREOF von ZHANG, Yu, DONG, Xin, ZHOU, Zhou, ZHAO, Lianqi, WANG, Binbin, DONG, Jinyu, WANG, Baiyang, WANG, Dong, SHAO, Liegang

Volltext bestellen

TIM-3-TARGETTING ANTIBODIES AND USES THEREOF von ZHANG, Yu, DONG, Xin, WANG, Binbin, DONG, Jinyu, GAO, Qian, WANG, Dong, WANG, Baiyang, SHAO, Liegang, WANG, Haojie, MA, Jun

Volltext bestellen

PD-L1 antibody, fusion protein and application thereof von SHAO LIEGANG, DONG JINYU, WANG DONG, WANG BINBIN, WANG BAIYANG, ZHANG YU, ZHAO LIANQI, DONG XIN, ZHOU ZHOU

Volltext bestellen

TIM-3-targeting antibodies and uses thereof von SHAO LIEGANG, DONG JINYU, WANG DONG, WANG BINBIN, GAO QIAN, WANG BAIYANG, WANG HAOJIE, MA JUN, ZHANG YU, DONG XIN

Volltext bestellen

Predictive values of ANGPTL8 on risk of all-cause mortality in diabetic patients: results from the REACTION Study von Zou, Huajie, Xu, Yongping, Chen, Xi, Yin, Ping, Li, Danpei, Li, Wenjun, Xie, Junhui, Shao, Shiying, Liu, Liegang, Yu, Xuefeng

Volltext

Circulating Betatrophin Levels Are Increased in Patients With Type 2 Diabetes and Associated With Insulin Resistance von Chen, Xi, Lu, Puhan, He, Wentao, Zhang, Jianhua, Liu, Lei, Yang, Yan, Liu, Zhelong, Xie, Junhui, Shao, Shiying, Du, Tingting, Su, Xianghui, Zhou, Xinrong, Hu, Shuhong, Yuan, Gang, Zhang, Muxun, Zhang, Hong, Liu, Liegang, Wang, Daowen, Yu, Xuefeng

Volltext

Exenatide Twice Daily Plus Glargine Versus Aspart 70/30 Twice Daily in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Premixed Human Insulin and Metformin von Chen, Xi, Xu, Yongping, Zhang, Jianhua, Shao, Shiyin, Duan, Yanran, Liu, Peiwen, Shen, Liya, Zhang, Jing, Zeng, Jiaoe, Lin, Mei, Zhao, Shi, Ma, Jianhua, Zhao, Tao, Hu, Juping, Liao, Yong, Chen, Xiaowen, Hu, Shufang, Xue, Yaoming, Zeng, Zhaoyang, He, Wentao, Liu, Zhelong, Li, Wenjun, Liu, Liegang, Yin, Ping, Yu, Xuefeng

Volltext

Cigarette production line light source performance detection device von ZHU JIANQIANG, ZHANG LIHONG, WANG JIANWEI, ZHU ZHOUHONG, ZHANG JUN, GONG YUEXIONG, CHEN LIEGANG, SHEN YUHANG, XIONG YUEHONG, YING WEI, WANG NENG, CHEN HUACAI, SHAO JUN

Volltext bestellen